Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
3/07/2014
A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
A new way to profile immune cells in blood
3/07/2014
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new paper in the journal Genome Biology, a team of scientists describes a new and uniquely advantageous way to detect them.
Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
3/07/2014
A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
A new way to profile immune cells in blood
3/07/2014
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new paper in the journal Genome Biology, a team of scientists describes a new and uniquely advantageous way to detect them.
Young nonmelanoma skin cancer survivors more likely to get other cancers later
3/07/2014
People who had nonmelanoma skin cancer (NMSC) were at increased risk for subsequently developing melanoma and 29 other cancer types, and this association was much higher for those under 25 years of age, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.NMSC is the most common type of skin cancer.
Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.
Young nonmelanoma skin cancer survivors more likely to get other cancers later
3/07/2014
People who had nonmelanoma skin cancer (NMSC) were at increased risk for subsequently developing melanoma and 29 other cancer types, and this association was much higher for those under 25 years of age, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.NMSC is the most common type of skin cancer.
Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.
British Psychological Society: Patients have a right to know - not a duty to know - their diagnosis
3/06/2014
Defensive mechanisms protect patients from fully engaging with bad news say healthcare professionals from the University of Leicester.
British Psychological Society: Patients have a right to know - not a duty to know - their diagnosis
3/06/2014
Defensive mechanisms protect patients from fully engaging with bad news say healthcare professionals from the University of Leicester.